【CHE】Cholinesterase Assay Kit (Butyrylthiocholine Substrate Method)

Background of Clinical Indications

It is used for the auxiliary diagnosis of hepatopathy and organophosphate poisoning, etc. Decrease is common in acute viral hepatitis, chronic hepatitis, hepatic cirrhosis, subacute severe hepatitis patients (especially patients with hepatic coma, who have a significant decrease in serum cholinesterase, and most of them show a persistent decrease ) and patients with extrahepatic biliary obstructive jaundice with biliary cirrhosis. Increase is mainly seen in patients with nephropathy, obesity, hyperthyroidism and other diseases, but also in patients with schizophrenia, hemolytic anemia, and megaloblastic anemia, etc.